Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Comment by chrispion May 01, 2021 5:11pm
194 Views
Post# 33109079

RE:RE:RE:RE:Bioasis, Chiesi and Protalix, Part 1

RE:RE:RE:RE:Bioasis, Chiesi and Protalix, Part 1
But most of all, I try to understand reality and discern possibilities. That's about it. It takes far more work to do that than it takes for a troll to fire off a bomb. And I think it's more honest and that's what I'll continue to do.

jd

JD, thanks for all the effort you put into explaining the science and understanding the immense possibilities that xB3 has.
Your 
last article was excellent!
<< Previous
Bullboard Posts
Next >>